Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LuLym-T (autologous activated lymphocytes)
i
Other names:
ATL
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Lujia Biomedical
Drug class:
VEGF inhibitor, Cell replacement
Related drugs:
‹
recombinant human endostatin (5)
ivonescimab (3)
BI 836880 (0)
CU06 (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
STAR-LLD SC (0)
ABT-510 (0)
AB-205 (0)
ASP0739 (0)
CBT101 (0)
rimiducid activated rivogenlecleucel (0)
MT-101 (0)
recombinant human endostatin (5)
ivonescimab (3)
BI 836880 (0)
CU06 (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
STAR-LLD SC (0)
ABT-510 (0)
AB-205 (0)
ASP0739 (0)
CBT101 (0)
rimiducid activated rivogenlecleucel (0)
MT-101 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login